Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.

导出原文传递

翻译打印收藏纠错

第一作者： Jonathan L,Curry

第一单位： Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

作者： Jonathan L,Curry ^[1] ; Michael T,Tetzlaff ^[2] ; Priyadharsini,Nagarajan ^[2] ; Carol,Drucker ^[3] ; Adi,Diab ^[4] ; Sharon R,Hymes ^[3] ; Madeleine,Duvic ^[3] ; Wen-Jen,Hwu ^[4] ; Jennifer A,Wargo ^[5] ; Carlos A,Torres-Cabala ^[1] ; Ronald P,Rapini ^[3] ; Victor G,Prieto ^[1]

作者单位： Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[1] Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[3] Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[4] Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[5]

关键词 anti-CTLA-4 anti-PD-1 anti-PD-L1 dermatologic toxicities immune checkpoint antibody

主题词抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);药疹(Drug Eruptions);人类(Humans)

DOI 10.1111/cup.12858

PMID 27859479

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交